The histone acetyltransferase Mof regulates Runx2 and Osterix for osteoblast differentiation
Cell and Tissue Research · 2023-08 · 393 (2) · 265-279
DOI: 10.1007/s00441-023-03791-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Tissue Research, online erschienen am 29.05.2023. Verfasst von Jianmei Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, 266237, China. Hauptthemen laut MEDLINE: Osteogenesis, Transcription Factors. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoblast differentiation is regulated by various transcription factors, signaling molecules, and posttranslational modifiers. The histone acetyltransferase Mof (Kat8) is involved in distinct physiological processes. However, the exact role of Mof in osteoblast differentiation and growth remains unknown. Herein, we demonstrated that Mof expression with histone H4K16 acetylation increased during osteoblast differentiation. Inhibition of Mof by siRNA knockdown or small molecule inhibitor, MG149 which is a potent histone acetyltransferase inhibitor, reduced the expression level and transactivation potential of osteogenic key markers, Runx2 and Osterix, thus inhibiting osteoblast differentiation. Besides, Mof overexpression also enhanced the protein levels of Runx2 and Osterix. Mof could directly bind the promoter region of Runx2/Osterix to potentiate their mRNA levels, possibly through Mof-mediated H4K16ac to facilitate the activation of transcriptional programs. Importantly, Mof physically interacts with Runx2/Osterix for the stimulation of osteoblast differentiation. Yet, Mof knockdown showed indistinguishable effect on cell proliferation or apoptosis in MSCs and preosteoblast cells. Taken together, our results uncover Mof functioning as a novel regulator of osteoblast differentiation via the promotional effects on Runx2/Osterix and rationalize Mof as a potential therapeutic target, like possible application of inhibitor MG149 for the treatment of osteosarcoma or developing specific Mof activator to ameliorate osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, 266237, China.
- School of Stomatology, Shandong University, Jinan, 250012, China.
- Qilu Hospital of Shandong University, Jinan, 250012, China.
- School of Pharmacy, Binzhou Medical University, Yantai, 264003, China.
- Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, 266237, China. olive3072002@aliyun.com.
- Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, 266237, China. xiangzhi@sdu.edu.cn.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Liu, D., Chen, B., Yang, Y., Zhu, H., Li, D., Liu, K., Zhu, L., Liu, H., Li, M., Zhang, X., & Li, X. (2023). The histone acetyltransferase Mof regulates Runx2 and Osterix for osteoblast differentiation. Cell and Tissue Research, 393(2), 265-279. https://doi.org/10.1007/s00441-023-03791-5
Vancouver
Chen J, Liu D, Chen B, Yang Y, Zhu H, Li D, et al. The histone acetyltransferase Mof regulates Runx2 and Osterix for osteoblast differentiation. Cell and Tissue Research. 2023;393(2):265-279. doi:10.1007/s00441-023-03791-5
BibTeX
@article{Chen2023,
author = {Chen, Jianmei and Liu, Di and Chen, Bo and Yang, Yang and Zhu, Hongying and Li, Danyang and Liu, Kun and Zhu, Lina and Liu, Hongrui and Li, Minqi and Zhang, Xu and Li, Xiangzhi},
title = {The histone acetyltransferase Mof regulates Runx2 and Osterix for osteoblast differentiation},
journal = {Cell and Tissue Research},
year = {2023},
volume = {393},
number = {2},
pages = {265--279},
doi = {10.1007/s00441-023-03791-5}
}
EUVIMED